← Human Trials & Peer-Reviewed Studies
Plasma insulin-like growth factor 1 distribution and its relation to blood pressure in adolescents: the Bogalusa Heart Study
Plain-language guide to PMID 9234824 (1997): clinical trial study of IGF-1 LR3, low blood pressure and orthostatic hypotension.
Key Facts
- PMID
- 9234824
- Journal
- American journal of hypertension
- Year
- 1997
- Study type
- Clinical Trial
- Authors
- Jiang X et al. (4 authors)
- DOI
- 10.1016/s0895-7061(97)00065-4
What This Study Did, in Plain Language
What Was Tested
Researchers studied IGF-1 LR3 in the context of low blood pressure and orthostatic hypotension in this clinical trial publication.
The distribution of circulating insulin-like growth factor-1 (IGF-1) and its relationship to blood pressure was examined in a community study of 1073 biracial (black-white) adolescents aged 11 to 18 years.
Who Took Part
PubMed indexes the participants as children and teenagers, both men and women.
What Was Measured
PubMed files the paper under topics including Aging, Blood Pressure, Insulin-Like Growth Factor I, Louisiana, Multivariate Analysis, Racial Groups and Risk Factors.
What This Means in Plain Language
This is a clinical trial of IGF-1 LR3 in people with low blood pressure and orthostatic hypotension.
The publication is from 1997 (American journal of hypertension), a journal based in United States.
More context: the IGF-1 LR3 compound page, Low blood pressure and orthostatic hypotension research.
Our Notes on the Compound
IGF-1 LR3: A modified IGF-1 analog that escapes binding proteins, so it stays active ≥24 h.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.